Mehul S.

Co-Founder

Elstree, United Kingdom

Experience

Nov 2024 - Nov 2025
1 year 1 month

Co-Founder

Wesimplifi

  • Co-founded a SaaS platform providing an AI-powered operating system for UK wealth managers to automate paraplanning, compliance and client reporting
  • Led product strategy and development, leveraging AI tools (Claude, Cursor) to build and iterate multiple MVPs improving adviser productivity
  • Managed a cross-functional team of 10 across engineering, design and compliance, operating in an agile development environment
  • Secured a strategic partnership with an incumbent advisory firm, including an acquisition offer for the platform
  • Conducted a strategic review of the business model and made the decision to pursue new opportunities following key learnings around product-market fit, GTM strategy, and scaling in a regulated space
Feb 2019 - Jul 2024
5 years 6 months

Associate (Third Year), Equity-Linked & Strategic Equity Derivatives

Barclays Investment Bank

  • Executed equity financing and derivative solutions for institutional investors, UHNWIs, family offices and FTSE-listed corporates, driving repeat client mandates across the UK franchise, including multi-billion-dollar transactions across call overwriting, collars, margin loans, exchangeables, and structured equity financings
  • Built and managed relationships with UK corporate treasury teams, securing repeat mandates for employee share option hedging and share buyback programmes
  • Led end-to-end deal execution, including structuring, pricing, negotiating legal and commercial terms, and coordinating internal approval processes across Risk, Legal, and Syndicate
  • Call writing for Blackstone on its stake in LSEG ($1bn)
  • Collar hedge for a global corporate on European underlying ($2.5bn)
  • Structured equity financing for a US private equity fund on a UK underlying ($2bn)
  • Equity bridge financing for ECP’s take private of Biffa (£200m)
  • Employee share options hedging transaction for a UK corporate via call options (£150m)
  • Monetisation of GSK’s stake in Theravance Biopharma via an exchangeable bond ($300m)
  • Fund financing for a European private equity fund (€1bn)
  • Margin loan for founder of a UK FTSE 250 corporate (£100m)
Jun 2017 - Aug 2017
3 months

Summer Analyst, Investment Management

State Street Global Advisors

  • Participated in a two-month internship within Institutional Product Development & Research across a range of asset classes and investment capabilities including separately managed accounts, traditional UCITS funds and alternative investments funds
  • Assessed the viability of launching a new offshore umbrella fund, including undertaking a detailed competitor analysis
  • Shadowed individuals from the Investment Solutions Group including the Tactical Asset Allocation team, acquired an understanding of SSGA’s tactical investment philosophy and process and the use of downside risk protection strategies such as target volatility triggers

Languages

English
Advanced

Education

Oct 2015 - Jun 2018

University of Warwick

Bachelor of Science · Economics · United Kingdom

Sep 2008 - Jul 2015

Haberdashers’ Aske’s School for Boys

Elstree, United Kingdom

Certifications & licenses

CISI Level 3 Certificates In Derivatives & Securities

CISI

Capital Markets Programme

CISI

Need a freelancer? Find your match in seconds.
Try FRATCH GPT
More actions